A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients.
D000293:Adolescent; D002986:Clinical Trials as Topic; D003989:Dibenzoxazepines; D004341:Drug Evaluation; D005260:Female; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008152:Loxapine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy*
D003989:Dibenzoxazepines; D006220:Haloperidol; D008152:Loxapine